Immunotherapy combination may benefit patients with transplanted kidneys and advanced skin cancers
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target skin cancers while preserving the transplanted organs.
Now, they report results from a clinical trial testing a novel drug combination designed to stimulate the immune system to fight advanced, potentially lethal skin cancers while not permanently damaging patients’ transplanted kidneys. The treatment included two immune-suppressing drugs ...













